Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Newregen Inc NREG

Newregen, Inc. provides anti-aging and regenerative medical treatments. It operates two brick and mortar and one Affiliated clinic. These are located in Atlanta, GA, Ft Lauderdale, FL and Tupelo MS. Its treatments have shown outcomes in autoimmune, inflammatory, neurological, and orthopedic conditions, injuries and other chronic pains. It is also focused on expanding its operations in FL and GA by adding additional affiliate clinics. It offers various services, including hormone replacement therapy, allograft suspension (stem cell) therapy, longevity, immunity, testosterone replacement therapy, weight management and others. It also offers multiple forms of hormone therapy, peptide therapy, cellular therapy, and other wellness therapies that complement their core services. The hormone replacement therapy treats a range of naturally occurring symptoms, including weight gain, increased body fat/decreased muscle mass, low energy, hair loss and others. Its subsidiary is ReGenMD, Inc.


OTCPK:NREG - Post by User

<< Previous
Bullboard Posts
Post by AveragePennyon Feb 22, 2022 10:49am
133 Views
Post# 34450141

Avra, Inc. Operating as Springs Rejuvenation (AVRN) Reports

Avra, Inc. Operating as Springs Rejuvenation (AVRN) Reports

ATLANTA, GA, Feb. 22, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Avra, Inc. (OTC PINK: AVRN), operating as Springs Rejuvenation, (“Springs”), a Chamblee, Georgia based anti-aging and stem cell center focusing on stem cell therapy, announced today a +200% increase in their 4th quarter earnings compared to the 3rd quarter. This is a substantial increase nearly matching All of the 3 previous quarters’ earnings combined, and strong growth is expected to continue. Avra’s annual report, filed on OTC Markets, shows a strong uptick of the company’s earnings post-merger. 

CEO Everett Dickson is quoted as saying, “It’s clear our marketing efforts are beginning to bear fruit. We have been retooling our digital footprint, beta testing several Google ads and launching a ‘boots on the ground’ campaign to increase the recognition of our clinics. We expect this trend to increase as our new locations open and our new C-Arm equipment expands our service offerings.”

https://www.globenewswire.com/news-release/2022/02/22/2389292/0/en/Avra-Inc-Operating-as-Springs-Rejuvenation-AVRN-Reports-a-200-Increase-in-Revenue-Post-Merger.html

<< Previous
Bullboard Posts